PetCaseFinder

Peer-reviewed veterinary case report

Long term phosphate binder diet helps cats with chronic kidney disease

By Biasibetti, E et al.·Published in Veterinary research communications·2018·University of Turin, Italy·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: A long term feed supplementation based on phosphate binders in Feline Chronic Kidney Disease.

Species:
cat

Plain-English summary

A group of 20 elderly cats with chronic kidney disease (CKD) were studied to see if a special dietary supplement could help improve their health. Half of the cats received the supplement for a year, while the other half only followed a renal diet. The results showed that the supplement helped lower phosphorus levels in the blood and increased bicarbonate levels, which can be beneficial for cats with advanced CKD. All the cats completed the study without any negative side effects, and their owners reported that the cats liked the taste of the supplement.

People also search for: cat chronic kidney disease treatment · cat kidney diet supplement · how to help my cat with kidney disease

Abstract

Chronic kidney disease (CKD) is a very common disorder in elderly cats. A proper renal diet represents the most efficient therapeutic intervention to improve survival and life quality in feline patients with 3 and 4 International Renal Interest Society (IRIS) stages. Twenty cats were selected in this study. Ten were administered the dietary supplementation for 360 days and the other ten, whose owners did not give consent for any supplemental therapies apart from the renal diet, were selected from a clinical database and used as control group. The present study is a long term study (360 days) aiming to evaluate the efficacy and palatability of a dietary supplementation containing calcium carbonate, calcium-lactate gluconate, chitosan and sodium bicarbonate in cats diagnosed with 3 and 4 IRIS stages of CKD. The owners were asked to fill in questionnaires to get information on the cat's appetite, the palatability of the given supplement, the presence of vomit and/or diarrhoea, general health and vitality. Hematochemical, biochemical and urinary analyses were performed on day 0, 30, 60, 90, 120, 150,180 and 360. GraphPad Prism® software was used to perform statistical analysis. Our study shows that the given dietary supplement reduced serum phosphorus and increased serum bicarbonate values in cats with CKD. In turn, this supplement could be used as a support therapy in cats with advanced CKD improving their clinical conditions without any adverse reaction. Finally, it is important to underline that all the animals completed the study and the owners reported a good palatability of the feed supplement.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/29582226/